Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry
Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE...
Gespeichert in:
Veröffentlicht in: | Journal of stroke and cerebrovascular diseases 2010-05, Vol.19 (3), p.190-197 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 197 |
---|---|
container_issue | 3 |
container_start_page | 190 |
container_title | Journal of stroke and cerebrovascular diseases |
container_volume | 19 |
creator | Uchiyama, Shinichiro, MD, PhD Shibata, Yoshisato, MD, PhD Hirabayashi, Takayuki, MD, PhD Mihara, Ban, MD, PhD Hamashige, Naohisa, MD, PhD Kitagawa, Kazuo, MD, PhD Goto, Shinya, MD, PhD Origasa, Hideki, PhD Shimada, Kazuyuki, MD, PhD Kobayashi, Hiroyuki, MD, PhD Isozaki, Mitsuhiro, PhD Ikeda, Yasuo, MD, PhD |
description | Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index > 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events. |
doi_str_mv | 10.1016/j.jstrokecerebrovasdis.2009.04.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733894563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1052305709000822</els_id><sourcerecordid>733894563</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</originalsourceid><addsrcrecordid>eNqVUk2P0zAQjRCIXRb-AvINCW3C2I6bhANSqSgs6gq0C2fLHxPkNI2LnVSq9s-vQxcOiAunscZP782bN1n2mkJBgS7edEUXx-C3aDCgDv6gonWxYABNAWUBUD7KzqngLK8FpY_TGwTLOYjqLHsWYwdAqajF0-yMQclLKMV5dnfj4paslRl9IF-Db12PkfiW3P5SuiTXR29UsE715GpoVTCj88MlUYMlyzHM7bXTwfW9mj_ekiX5rPZqwIjkeupHZ3AYMZCV93sMCXNAcoM_XDJyfJ49aVUf8cVDvci-rz98W33KN18-Xq2Wm9wIVo45bYxl2iJwTlWlKqx1xRe6plrohS1tg1WLyVEFjWlrppmmteZNYy1waqHlF9mrE-8--J8TxlHuXDSYRh7QT1FWnNdNKRY8Id-fkCb4GAO2ch_cToWjpCDnDGQn_5WBnDOQUMqUQSJ5-SA36R3aPxS_l54AmxMAk-mDwyCjcTgYtC6gGaX17v_03v1FZ3o3OKP6LR4xdn4KQ1qvpDIyCfJ2vor5KKABgJoxfg-4zL0s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733894563</pqid></control><display><type>article</type><title>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Uchiyama, Shinichiro, MD, PhD ; Shibata, Yoshisato, MD, PhD ; Hirabayashi, Takayuki, MD, PhD ; Mihara, Ban, MD, PhD ; Hamashige, Naohisa, MD, PhD ; Kitagawa, Kazuo, MD, PhD ; Goto, Shinya, MD, PhD ; Origasa, Hideki, PhD ; Shimada, Kazuyuki, MD, PhD ; Kobayashi, Hiroyuki, MD, PhD ; Isozaki, Mitsuhiro, PhD ; Ikeda, Yasuo, MD, PhD</creator><creatorcontrib>Uchiyama, Shinichiro, MD, PhD ; Shibata, Yoshisato, MD, PhD ; Hirabayashi, Takayuki, MD, PhD ; Mihara, Ban, MD, PhD ; Hamashige, Naohisa, MD, PhD ; Kitagawa, Kazuo, MD, PhD ; Goto, Shinya, MD, PhD ; Origasa, Hideki, PhD ; Shimada, Kazuyuki, MD, PhD ; Kobayashi, Hiroyuki, MD, PhD ; Isozaki, Mitsuhiro, PhD ; Ikeda, Yasuo, MD, PhD ; J-TRACE Investigators</creatorcontrib><description>Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index > 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2009.04.004</identifier><identifier>PMID: 20434045</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; atrial fibrillation ; Atrial Fibrillation - epidemiology ; Cardiomyopathy, Dilated - complications ; Cardiomyopathy, Dilated - epidemiology ; Cardiovascular ; Cohort Studies ; Data Interpretation, Statistical ; Diabetes Mellitus - epidemiology ; Female ; Fibrinolytic Agents - therapeutic use ; Humans ; Hypercholesterolemia - complications ; Hypercholesterolemia - epidemiology ; Hypertension - complications ; Hypertension - drug therapy ; Hypertension - epidemiology ; Japan - epidemiology ; Male ; Middle Aged ; myocardial infarction ; Myocardial Infarction - drug therapy ; Myocardial Infarction - epidemiology ; Neurology ; Registries ; Registry ; Risk factor ; Risk Factors ; stroke ; Stroke - drug therapy ; Stroke - epidemiology ; Thrombosis - complications</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2010-05, Vol.19 (3), p.190-197</ispartof><rights>National Stroke Association</rights><rights>2010 National Stroke Association</rights><rights>Copyright (c) 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</citedby><cites>FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2009.04.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20434045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uchiyama, Shinichiro, MD, PhD</creatorcontrib><creatorcontrib>Shibata, Yoshisato, MD, PhD</creatorcontrib><creatorcontrib>Hirabayashi, Takayuki, MD, PhD</creatorcontrib><creatorcontrib>Mihara, Ban, MD, PhD</creatorcontrib><creatorcontrib>Hamashige, Naohisa, MD, PhD</creatorcontrib><creatorcontrib>Kitagawa, Kazuo, MD, PhD</creatorcontrib><creatorcontrib>Goto, Shinya, MD, PhD</creatorcontrib><creatorcontrib>Origasa, Hideki, PhD</creatorcontrib><creatorcontrib>Shimada, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Kobayashi, Hiroyuki, MD, PhD</creatorcontrib><creatorcontrib>Isozaki, Mitsuhiro, PhD</creatorcontrib><creatorcontrib>Ikeda, Yasuo, MD, PhD</creatorcontrib><creatorcontrib>J-TRACE Investigators</creatorcontrib><title>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index > 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events.</description><subject>Aged</subject><subject>atrial fibrillation</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Cardiomyopathy, Dilated - complications</subject><subject>Cardiomyopathy, Dilated - epidemiology</subject><subject>Cardiovascular</subject><subject>Cohort Studies</subject><subject>Data Interpretation, Statistical</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Humans</subject><subject>Hypercholesterolemia - complications</subject><subject>Hypercholesterolemia - epidemiology</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Japan - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>myocardial infarction</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Neurology</subject><subject>Registries</subject><subject>Registry</subject><subject>Risk factor</subject><subject>Risk Factors</subject><subject>stroke</subject><subject>Stroke - drug therapy</subject><subject>Stroke - epidemiology</subject><subject>Thrombosis - complications</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVUk2P0zAQjRCIXRb-AvINCW3C2I6bhANSqSgs6gq0C2fLHxPkNI2LnVSq9s-vQxcOiAunscZP782bN1n2mkJBgS7edEUXx-C3aDCgDv6gonWxYABNAWUBUD7KzqngLK8FpY_TGwTLOYjqLHsWYwdAqajF0-yMQclLKMV5dnfj4paslRl9IF-Db12PkfiW3P5SuiTXR29UsE715GpoVTCj88MlUYMlyzHM7bXTwfW9mj_ekiX5rPZqwIjkeupHZ3AYMZCV93sMCXNAcoM_XDJyfJ49aVUf8cVDvci-rz98W33KN18-Xq2Wm9wIVo45bYxl2iJwTlWlKqx1xRe6plrohS1tg1WLyVEFjWlrppmmteZNYy1waqHlF9mrE-8--J8TxlHuXDSYRh7QT1FWnNdNKRY8Id-fkCb4GAO2ch_cToWjpCDnDGQn_5WBnDOQUMqUQSJ5-SA36R3aPxS_l54AmxMAk-mDwyCjcTgYtC6gGaX17v_03v1FZ3o3OKP6LR4xdn4KQ1qvpDIyCfJ2vor5KKABgJoxfg-4zL0s</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Uchiyama, Shinichiro, MD, PhD</creator><creator>Shibata, Yoshisato, MD, PhD</creator><creator>Hirabayashi, Takayuki, MD, PhD</creator><creator>Mihara, Ban, MD, PhD</creator><creator>Hamashige, Naohisa, MD, PhD</creator><creator>Kitagawa, Kazuo, MD, PhD</creator><creator>Goto, Shinya, MD, PhD</creator><creator>Origasa, Hideki, PhD</creator><creator>Shimada, Kazuyuki, MD, PhD</creator><creator>Kobayashi, Hiroyuki, MD, PhD</creator><creator>Isozaki, Mitsuhiro, PhD</creator><creator>Ikeda, Yasuo, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100501</creationdate><title>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</title><author>Uchiyama, Shinichiro, MD, PhD ; Shibata, Yoshisato, MD, PhD ; Hirabayashi, Takayuki, MD, PhD ; Mihara, Ban, MD, PhD ; Hamashige, Naohisa, MD, PhD ; Kitagawa, Kazuo, MD, PhD ; Goto, Shinya, MD, PhD ; Origasa, Hideki, PhD ; Shimada, Kazuyuki, MD, PhD ; Kobayashi, Hiroyuki, MD, PhD ; Isozaki, Mitsuhiro, PhD ; Ikeda, Yasuo, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>atrial fibrillation</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Cardiomyopathy, Dilated - complications</topic><topic>Cardiomyopathy, Dilated - epidemiology</topic><topic>Cardiovascular</topic><topic>Cohort Studies</topic><topic>Data Interpretation, Statistical</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Humans</topic><topic>Hypercholesterolemia - complications</topic><topic>Hypercholesterolemia - epidemiology</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Japan - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>myocardial infarction</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Neurology</topic><topic>Registries</topic><topic>Registry</topic><topic>Risk factor</topic><topic>Risk Factors</topic><topic>stroke</topic><topic>Stroke - drug therapy</topic><topic>Stroke - epidemiology</topic><topic>Thrombosis - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uchiyama, Shinichiro, MD, PhD</creatorcontrib><creatorcontrib>Shibata, Yoshisato, MD, PhD</creatorcontrib><creatorcontrib>Hirabayashi, Takayuki, MD, PhD</creatorcontrib><creatorcontrib>Mihara, Ban, MD, PhD</creatorcontrib><creatorcontrib>Hamashige, Naohisa, MD, PhD</creatorcontrib><creatorcontrib>Kitagawa, Kazuo, MD, PhD</creatorcontrib><creatorcontrib>Goto, Shinya, MD, PhD</creatorcontrib><creatorcontrib>Origasa, Hideki, PhD</creatorcontrib><creatorcontrib>Shimada, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Kobayashi, Hiroyuki, MD, PhD</creatorcontrib><creatorcontrib>Isozaki, Mitsuhiro, PhD</creatorcontrib><creatorcontrib>Ikeda, Yasuo, MD, PhD</creatorcontrib><creatorcontrib>J-TRACE Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uchiyama, Shinichiro, MD, PhD</au><au>Shibata, Yoshisato, MD, PhD</au><au>Hirabayashi, Takayuki, MD, PhD</au><au>Mihara, Ban, MD, PhD</au><au>Hamashige, Naohisa, MD, PhD</au><au>Kitagawa, Kazuo, MD, PhD</au><au>Goto, Shinya, MD, PhD</au><au>Origasa, Hideki, PhD</au><au>Shimada, Kazuyuki, MD, PhD</au><au>Kobayashi, Hiroyuki, MD, PhD</au><au>Isozaki, Mitsuhiro, PhD</au><au>Ikeda, Yasuo, MD, PhD</au><aucorp>J-TRACE Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>19</volume><issue>3</issue><spage>190</spage><epage>197</epage><pages>190-197</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index > 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20434045</pmid><doi>10.1016/j.jstrokecerebrovasdis.2009.04.004</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1052-3057 |
ispartof | Journal of stroke and cerebrovascular diseases, 2010-05, Vol.19 (3), p.190-197 |
issn | 1052-3057 1532-8511 |
language | eng |
recordid | cdi_proquest_miscellaneous_733894563 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Aged atrial fibrillation Atrial Fibrillation - epidemiology Cardiomyopathy, Dilated - complications Cardiomyopathy, Dilated - epidemiology Cardiovascular Cohort Studies Data Interpretation, Statistical Diabetes Mellitus - epidemiology Female Fibrinolytic Agents - therapeutic use Humans Hypercholesterolemia - complications Hypercholesterolemia - epidemiology Hypertension - complications Hypertension - drug therapy Hypertension - epidemiology Japan - epidemiology Male Middle Aged myocardial infarction Myocardial Infarction - drug therapy Myocardial Infarction - epidemiology Neurology Registries Registry Risk factor Risk Factors stroke Stroke - drug therapy Stroke - epidemiology Thrombosis - complications |
title | Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T08%3A23%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20Factor%20Profiles%20of%20Stroke,%20Myocardial%20Infarction,%20and%20Atrial%20Fibrillation:%20A%20Japanese%20Multicenter%20Cooperative%20Registry&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Uchiyama,%20Shinichiro,%20MD,%20PhD&rft.aucorp=J-TRACE%20Investigators&rft.date=2010-05-01&rft.volume=19&rft.issue=3&rft.spage=190&rft.epage=197&rft.pages=190-197&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2009.04.004&rft_dat=%3Cproquest_cross%3E733894563%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733894563&rft_id=info:pmid/20434045&rft_els_id=S1052305709000822&rfr_iscdi=true |